| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 5 | 2016 | 37 | 1.260 |
Why?
|
| Humans | 89 | 2024 | 18430 | 1.200 |
Why?
|
| Genetic Carrier Screening | 6 | 2018 | 22 | 1.160 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2019 | 61 | 1.130 |
Why?
|
| Female | 73 | 2024 | 13136 | 1.080 |
Why?
|
| Male | 57 | 2021 | 10440 | 1.000 |
Why?
|
| Community Health Centers | 8 | 2021 | 112 | 0.950 |
Why?
|
| Genetic Counseling | 8 | 2023 | 35 | 0.920 |
Why?
|
| Early Detection of Cancer | 5 | 2023 | 526 | 0.890 |
Why?
|
| Adult | 50 | 2024 | 7910 | 0.880 |
Why?
|
| Surveys and Questionnaires | 13 | 2019 | 1389 | 0.860 |
Why?
|
| Middle Aged | 48 | 2023 | 8284 | 0.860 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2018 | 12 | 0.830 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 39 | 0.800 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 656 | 0.790 |
Why?
|
| Depression | 4 | 2020 | 518 | 0.740 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 249 | 0.740 |
Why?
|
| Genetic Testing | 7 | 2023 | 89 | 0.730 |
Why?
|
| Family | 3 | 2018 | 120 | 0.700 |
Why?
|
| Family Planning Services | 3 | 2017 | 27 | 0.700 |
Why?
|
| Genome, Human | 3 | 2016 | 42 | 0.700 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2020 | 74 | 0.680 |
Why?
|
| Graves Ophthalmopathy | 4 | 2020 | 4 | 0.660 |
Why?
|
| Curriculum | 3 | 2024 | 40 | 0.660 |
Why?
|
| Xylitol | 3 | 2013 | 10 | 0.660 |
Why?
|
| Public Health | 1 | 2019 | 82 | 0.660 |
Why?
|
| Pit and Fissure Sealants | 2 | 2016 | 11 | 0.640 |
Why?
|
| Aged | 33 | 2020 | 6417 | 0.620 |
Why?
|
| Antipsychotic Agents | 5 | 2016 | 57 | 0.610 |
Why?
|
| Gynecology | 3 | 2024 | 23 | 0.580 |
Why?
|
| Preconception Care | 5 | 2018 | 48 | 0.570 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 13 | 0.560 |
Why?
|
| Orthodontic Anchorage Procedures | 1 | 2016 | 1 | 0.550 |
Why?
|
| Evidence-Based Practice | 3 | 2016 | 56 | 0.550 |
Why?
|
| Dental Implants | 1 | 2016 | 3 | 0.550 |
Why?
|
| Sweetening Agents | 2 | 2013 | 12 | 0.550 |
Why?
|
| Cariostatic Agents | 2 | 2013 | 12 | 0.540 |
Why?
|
| Chiropractic | 2 | 2012 | 12 | 0.530 |
Why?
|
| Critical Care | 1 | 2016 | 73 | 0.530 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 1037 | 0.490 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 127 | 0.490 |
Why?
|
| Young Adult | 16 | 2023 | 2518 | 0.490 |
Why?
|
| Quality of Health Care | 2 | 2016 | 347 | 0.490 |
Why?
|
| Decision Making | 9 | 2020 | 204 | 0.480 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2018 | 70 | 0.470 |
Why?
|
| Health Promotion | 4 | 2021 | 294 | 0.470 |
Why?
|
| Health Status | 4 | 2016 | 328 | 0.470 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 38 | 0.440 |
Why?
|
| Genomics | 6 | 2020 | 66 | 0.440 |
Why?
|
| Adolescent | 16 | 2021 | 3798 | 0.430 |
Why?
|
| Treatment Outcome | 15 | 2021 | 1296 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2020 | 350 | 0.410 |
Why?
|
| Occult Blood | 3 | 2023 | 167 | 0.400 |
Why?
|
| Cost-Benefit Analysis | 5 | 2019 | 270 | 0.370 |
Why?
|
| Behavior Therapy | 3 | 2021 | 155 | 0.370 |
Why?
|
| Pregnancy | 7 | 2024 | 1516 | 0.370 |
Why?
|
| Reminder Systems | 2 | 2023 | 94 | 0.370 |
Why?
|
| Motivation | 3 | 2019 | 137 | 0.370 |
Why?
|
| Weight Loss | 5 | 2015 | 321 | 0.360 |
Why?
|
| Attitude to Health | 5 | 2015 | 177 | 0.360 |
Why?
|
| Overweight | 5 | 2016 | 276 | 0.360 |
Why?
|
| Obesity | 5 | 2023 | 855 | 0.360 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 2003 | 0.360 |
Why?
|
| Occupational Health | 2 | 2007 | 21 | 0.350 |
Why?
|
| Smoking Cessation | 3 | 2024 | 199 | 0.350 |
Why?
|
| United States | 15 | 2024 | 4164 | 0.350 |
Why?
|
| Cystectomy | 2 | 2019 | 8 | 0.350 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 95 | 0.340 |
Why?
|
| Life Style | 4 | 2015 | 342 | 0.340 |
Why?
|
| Mass Screening | 3 | 2023 | 690 | 0.340 |
Why?
|
| Resistance Training | 4 | 2012 | 8 | 0.330 |
Why?
|
| Patient Compliance | 3 | 2019 | 318 | 0.310 |
Why?
|
| Child | 11 | 2021 | 2571 | 0.310 |
Why?
|
| Cholesterol | 2 | 2018 | 112 | 0.300 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 399 | 0.280 |
Why?
|
| Risk Assessment | 7 | 2019 | 1143 | 0.280 |
Why?
|
| Biomarkers | 4 | 2020 | 308 | 0.270 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 60 | 0.260 |
Why?
|
| Quality Improvement | 3 | 2023 | 207 | 0.250 |
Why?
|
| Mental Disorders | 4 | 2016 | 295 | 0.250 |
Why?
|
| Child Behavior | 4 | 2018 | 25 | 0.250 |
Why?
|
| Prognosis | 4 | 2020 | 624 | 0.250 |
Why?
|
| Psychotic Disorders | 3 | 2015 | 47 | 0.250 |
Why?
|
| Emigrants and Immigrants | 3 | 2014 | 31 | 0.250 |
Why?
|
| Telephone | 2 | 2023 | 179 | 0.250 |
Why?
|
| Primary Health Care | 4 | 2020 | 848 | 0.250 |
Why?
|
| Parents | 2 | 2020 | 309 | 0.250 |
Why?
|
| End Stage Liver Disease | 2 | 2015 | 11 | 0.240 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 182 | 0.240 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 1269 | 0.240 |
Why?
|
| Risk Factors | 7 | 2023 | 3449 | 0.240 |
Why?
|
| Psychology, Child | 2 | 2005 | 6 | 0.240 |
Why?
|
| Research Design | 4 | 2020 | 402 | 0.230 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2023 | 7 | 0.230 |
Why?
|
| Menopause | 2 | 2024 | 72 | 0.230 |
Why?
|
| Nursing Homes | 2 | 2014 | 10 | 0.230 |
Why?
|
| Obstetrics | 1 | 2024 | 23 | 0.230 |
Why?
|
| Adaptation, Psychological | 2 | 2005 | 82 | 0.230 |
Why?
|
| Body Mass Index | 5 | 2021 | 974 | 0.230 |
Why?
|
| Internship and Residency | 1 | 2024 | 50 | 0.220 |
Why?
|
| Diabetes Mellitus | 3 | 2017 | 530 | 0.220 |
Why?
|
| Survivors | 4 | 2012 | 158 | 0.220 |
Why?
|
| Bone Density | 3 | 2012 | 96 | 0.220 |
Why?
|
| Psychology, Adolescent | 1 | 2003 | 15 | 0.220 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 444 | 0.220 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 193 | 0.220 |
Why?
|
| Substance Abuse Detection | 1 | 2002 | 19 | 0.210 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 1360 | 0.210 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 630 | 0.210 |
Why?
|
| Mothers | 4 | 2018 | 110 | 0.210 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 43 | 0.210 |
Why?
|
| Marijuana Abuse | 1 | 2002 | 41 | 0.200 |
Why?
|
| Counseling | 4 | 2016 | 197 | 0.200 |
Why?
|
| Health Literacy | 1 | 2022 | 40 | 0.200 |
Why?
|
| Exome | 3 | 2016 | 25 | 0.200 |
Why?
|
| Organ Size | 1 | 2021 | 16 | 0.200 |
Why?
|
| Prospective Studies | 8 | 2023 | 1314 | 0.200 |
Why?
|
| Disease Progression | 2 | 2020 | 271 | 0.200 |
Why?
|
| Asian Americans | 2 | 2013 | 182 | 0.200 |
Why?
|
| Incidental Findings | 3 | 2016 | 30 | 0.200 |
Why?
|
| Liver | 1 | 2021 | 33 | 0.200 |
Why?
|
| Safety-net Providers | 2 | 2020 | 63 | 0.200 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2012 | 44 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 127 | 0.200 |
Why?
|
| Exercise Therapy | 2 | 2012 | 74 | 0.190 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 232 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2019 | 407 | 0.190 |
Why?
|
| Quality of Life | 3 | 2019 | 529 | 0.190 |
Why?
|
| Oregon | 5 | 2020 | 222 | 0.190 |
Why?
|
| Counselors | 1 | 2020 | 1 | 0.190 |
Why?
|
| Receptors, Thyrotropin | 1 | 2020 | 2 | 0.180 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.180 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.180 |
Why?
|
| Urologic Diseases | 1 | 2020 | 8 | 0.180 |
Why?
|
| Electronic Health Records | 5 | 2017 | 747 | 0.180 |
Why?
|
| Clinical Competence | 3 | 2024 | 108 | 0.180 |
Why?
|
| Depressive Disorder | 2 | 2018 | 231 | 0.180 |
Why?
|
| Sleep Hygiene | 1 | 2020 | 4 | 0.180 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 9 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 80 | 0.180 |
Why?
|
| Dyslipidemias | 2 | 2017 | 65 | 0.170 |
Why?
|
| Stress, Psychological | 3 | 2018 | 147 | 0.170 |
Why?
|
| Patient Navigation | 1 | 2019 | 17 | 0.170 |
Why?
|
| Urinary Diversion | 1 | 2019 | 3 | 0.170 |
Why?
|
| Documentation | 1 | 2020 | 45 | 0.170 |
Why?
|
| Heterozygote | 2 | 2016 | 29 | 0.170 |
Why?
|
| Terminology as Topic | 2 | 2016 | 21 | 0.170 |
Why?
|
| Referral and Consultation | 2 | 2019 | 180 | 0.160 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 93 | 0.160 |
Why?
|
| Maxilla | 2 | 2016 | 2 | 0.160 |
Why?
|
| Mandible | 2 | 2016 | 4 | 0.160 |
Why?
|
| Health Policy | 1 | 2020 | 136 | 0.160 |
Why?
|
| Cancer Survivors | 1 | 2019 | 89 | 0.160 |
Why?
|
| Neonatal Screening | 1 | 2018 | 13 | 0.160 |
Why?
|
| Neoplasms | 2 | 2020 | 457 | 0.160 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 162 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 36 | 0.150 |
Why?
|
| Double-Blind Method | 3 | 2013 | 165 | 0.150 |
Why?
|
| Mental Health Services | 2 | 2013 | 161 | 0.150 |
Why?
|
| Colonoscopy | 1 | 2019 | 268 | 0.150 |
Why?
|
| Pilot Projects | 5 | 2019 | 237 | 0.150 |
Why?
|
| Health Expenditures | 1 | 2018 | 82 | 0.150 |
Why?
|
| American Heart Association | 1 | 2017 | 50 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 392 | 0.140 |
Why?
|
| Smoking | 1 | 2020 | 494 | 0.140 |
Why?
|
| Primary Prevention | 1 | 2017 | 79 | 0.140 |
Why?
|
| Northwestern United States | 1 | 2016 | 58 | 0.140 |
Why?
|
| Postnatal Care | 1 | 2016 | 22 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2016 | 21 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2016 | 25 | 0.140 |
Why?
|
| Fluorides | 2 | 2013 | 8 | 0.140 |
Why?
|
| DMF Index | 2 | 2013 | 10 | 0.140 |
Why?
|
| Dental Caries Susceptibility | 2 | 2013 | 15 | 0.140 |
Why?
|
| Weight Gain | 2 | 2016 | 181 | 0.140 |
Why?
|
| Root Caries | 2 | 2013 | 9 | 0.140 |
Why?
|
| Placebos | 2 | 2013 | 23 | 0.140 |
Why?
|
| Laboratories | 1 | 2016 | 23 | 0.140 |
Why?
|
| Truth Disclosure | 1 | 2016 | 17 | 0.130 |
Why?
|
| Treatment Refusal | 1 | 2016 | 38 | 0.130 |
Why?
|
| Drug Utilization | 1 | 2016 | 134 | 0.130 |
Why?
|
| Patient Participation | 2 | 2019 | 144 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2016 | 87 | 0.130 |
Why?
|
| Medical Records | 1 | 2016 | 106 | 0.130 |
Why?
|
| Palliative Care | 1 | 2016 | 58 | 0.130 |
Why?
|
| Health Education | 2 | 2013 | 115 | 0.130 |
Why?
|
| Body Image | 1 | 2015 | 22 | 0.130 |
Why?
|
| Mutation | 1 | 2016 | 132 | 0.130 |
Why?
|
| Preimplantation Diagnosis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Health Care Costs | 2 | 2010 | 251 | 0.130 |
Why?
|
| Prostatectomy | 1 | 2015 | 79 | 0.130 |
Why?
|
| Risk Reduction Behavior | 3 | 2016 | 114 | 0.130 |
Why?
|
| Critical Illness | 1 | 2016 | 53 | 0.130 |
Why?
|
| Social Determinants of Health | 1 | 2016 | 47 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2015 | 214 | 0.130 |
Why?
|
| Self Efficacy | 1 | 2015 | 71 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2016 | 93 | 0.130 |
Why?
|
| Communication | 3 | 2022 | 202 | 0.130 |
Why?
|
| Muscle Strength | 2 | 2011 | 14 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2016 | 106 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 333 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2016 | 134 | 0.120 |
Why?
|
| Glycated Hemoglobin A | 1 | 2016 | 233 | 0.120 |
Why?
|
| Psychometrics | 2 | 2012 | 124 | 0.120 |
Why?
|
| Group Processes | 1 | 2014 | 12 | 0.120 |
Why?
|
| Health Facility Administrators | 1 | 2014 | 3 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 146 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 54 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 2014 | 2 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 3 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 28 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2013 | 28 | 0.120 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2013 | 10 | 0.120 |
Why?
|
| Postmenopause | 2 | 2012 | 267 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 29 | 0.110 |
Why?
|
| Pain Management | 1 | 2014 | 59 | 0.110 |
Why?
|
| Nurse Administrators | 1 | 2013 | 8 | 0.110 |
Why?
|
| Homes for the Aged | 1 | 2013 | 6 | 0.110 |
Why?
|
| Nurse's Role | 1 | 2013 | 8 | 0.110 |
Why?
|
| Professional Competence | 1 | 2013 | 12 | 0.110 |
Why?
|
| Schizophrenia | 1 | 2013 | 79 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 50 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 760 | 0.110 |
Why?
|
| Tooth Loss | 1 | 2013 | 4 | 0.110 |
Why?
|
| Crowns | 1 | 2013 | 5 | 0.110 |
Why?
|
| Dentin | 1 | 2013 | 12 | 0.110 |
Why?
|
| Dental Enamel | 1 | 2013 | 12 | 0.110 |
Why?
|
| Students, Health Occupations | 1 | 2012 | 1 | 0.110 |
Why?
|
| Leadership | 1 | 2013 | 45 | 0.110 |
Why?
|
| Dental Restoration, Permanent | 1 | 2013 | 24 | 0.110 |
Why?
|
| Focus Groups | 3 | 2020 | 154 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2012 | 19 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 298 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 476 | 0.110 |
Why?
|
| Menopause, Premature | 1 | 2012 | 4 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2013 | 86 | 0.110 |
Why?
|
| Self Care | 1 | 2014 | 175 | 0.100 |
Why?
|
| Cognition | 2 | 2015 | 82 | 0.100 |
Why?
|
| Hand Strength | 1 | 2011 | 11 | 0.100 |
Why?
|
| Alveolar Process | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cephalometry | 1 | 2011 | 2 | 0.100 |
Why?
|
| Mammography | 1 | 2013 | 174 | 0.100 |
Why?
|
| Linear Models | 3 | 2017 | 243 | 0.100 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 439 | 0.100 |
Why?
|
| Induction Chemotherapy | 1 | 2011 | 4 | 0.100 |
Why?
|
| Hip Fractures | 1 | 2012 | 68 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 10 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2012 | 76 | 0.100 |
Why?
|
| Fatigue | 1 | 2011 | 35 | 0.100 |
Why?
|
| Postural Balance | 1 | 2011 | 11 | 0.100 |
Why?
|
| Dental Plaque | 1 | 2011 | 1 | 0.100 |
Why?
|
| Orthodontic Appliance Design | 1 | 2011 | 1 | 0.100 |
Why?
|
| Orthodontic Brackets | 1 | 2011 | 1 | 0.100 |
Why?
|
| Dental Caries Activity Tests | 1 | 2011 | 2 | 0.100 |
Why?
|
| HIV Infections | 1 | 2017 | 695 | 0.090 |
Why?
|
| Interviews as Topic | 3 | 2019 | 327 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2011 | 38 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2011 | 40 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 226 | 0.090 |
Why?
|
| Methadone | 1 | 2010 | 11 | 0.090 |
Why?
|
| Prepaid Health Plans | 1 | 2010 | 22 | 0.090 |
Why?
|
| Opiate Substitution Treatment | 1 | 2010 | 45 | 0.090 |
Why?
|
| Urinary Bladder | 2 | 2019 | 11 | 0.090 |
Why?
|
| Community Health Services | 2 | 2012 | 86 | 0.090 |
Why?
|
| Hispanic Americans | 2 | 2021 | 428 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2018 | 872 | 0.080 |
Why?
|
| Socioeconomic Factors | 3 | 2021 | 673 | 0.080 |
Why?
|
| Ethnic Groups | 3 | 2021 | 501 | 0.080 |
Why?
|
| Time Factors | 3 | 2019 | 1136 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2016 | 272 | 0.080 |
Why?
|
| Diet | 3 | 2016 | 371 | 0.080 |
Why?
|
| Bacopa | 1 | 2008 | 1 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2008 | 14 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2008 | 13 | 0.080 |
Why?
|
| Exercise | 4 | 2016 | 495 | 0.080 |
Why?
|
| Mental Health | 1 | 2009 | 168 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 168 | 0.070 |
Why?
|
| Anxiety | 1 | 2008 | 156 | 0.070 |
Why?
|
| Nursing Methodology Research | 2 | 2005 | 8 | 0.070 |
Why?
|
| Prevalence | 2 | 2021 | 911 | 0.070 |
Why?
|
| Adolescent Behavior | 2 | 2011 | 129 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2006 | 87 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 342 | 0.070 |
Why?
|
| California | 3 | 2016 | 2365 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 962 | 0.070 |
Why?
|
| Family Health | 1 | 2005 | 49 | 0.060 |
Why?
|
| Family Relations | 1 | 2005 | 18 | 0.060 |
Why?
|
| Models, Psychological | 1 | 2005 | 25 | 0.060 |
Why?
|
| Gestational Age | 2 | 2016 | 119 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 414 | 0.060 |
Why?
|
| Mastectomy | 1 | 2005 | 39 | 0.060 |
Why?
|
| Energy Intake | 2 | 2015 | 103 | 0.060 |
Why?
|
| Guidelines as Topic | 2 | 2016 | 43 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 109 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2016 | 2550 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2004 | 76 | 0.060 |
Why?
|
| Ambulatory Care | 2 | 2016 | 266 | 0.060 |
Why?
|
| Vaginal Smears | 2 | 2014 | 50 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 724 | 0.060 |
Why?
|
| Emotions | 1 | 2003 | 35 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2023 | 15 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 41 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2023 | 60 | 0.050 |
Why?
|
| Self Concept | 1 | 2003 | 42 | 0.050 |
Why?
|
| Organizational Policy | 1 | 2002 | 17 | 0.050 |
Why?
|
| Lipids | 1 | 2023 | 78 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2022 | 23 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 3 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2021 | 3 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 6 | 0.050 |
Why?
|
| Parturition | 1 | 2021 | 10 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2021 | 20 | 0.050 |
Why?
|
| Glucose | 1 | 2021 | 30 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2012 | 167 | 0.050 |
Why?
|
| Incisor | 2 | 2011 | 4 | 0.050 |
Why?
|
| Data Collection | 1 | 2022 | 275 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 375 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 337 | 0.050 |
Why?
|
| Syndrome | 1 | 2020 | 29 | 0.050 |
Why?
|
| Immunoassay | 1 | 2020 | 9 | 0.050 |
Why?
|
| Facial Asymmetry | 1 | 2020 | 1 | 0.050 |
Why?
|
| European Continental Ancestry Group | 1 | 2003 | 554 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 743 | 0.040 |
Why?
|
| African Americans | 1 | 2003 | 490 | 0.040 |
Why?
|
| Urologists | 1 | 2019 | 3 | 0.040 |
Why?
|
| Atrophy | 1 | 2019 | 6 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 80 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 83 | 0.040 |
Why?
|
| Mentoring | 1 | 2019 | 28 | 0.040 |
Why?
|
| Attitude | 1 | 2019 | 33 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 388 | 0.040 |
Why?
|
| Minority Groups | 1 | 2019 | 105 | 0.040 |
Why?
|
| Text Messaging | 1 | 2019 | 31 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2018 | 3 | 0.040 |
Why?
|
| Postal Service | 1 | 2019 | 83 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 15 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 214 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2018 | 12 | 0.040 |
Why?
|
| Income | 1 | 2018 | 98 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 23 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 41 | 0.040 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 26 | 0.040 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2018 | 254 | 0.040 |
Why?
|
| Health Services Research | 1 | 2018 | 264 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 7 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2016 | 6 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 12 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 13 | 0.030 |
Why?
|
| Software | 1 | 2016 | 21 | 0.030 |
Why?
|
| Nurses | 1 | 2016 | 40 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2017 | 162 | 0.030 |
Why?
|
| Language | 1 | 2016 | 52 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2015 | 18 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 36 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 83 | 0.030 |
Why?
|
| Inpatients | 1 | 2016 | 80 | 0.030 |
Why?
|
| Prostate | 1 | 2015 | 29 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 83 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 180 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 598 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 197 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 131 | 0.030 |
Why?
|
| Nutritionists | 1 | 2015 | 1 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 129 | 0.030 |
Why?
|
| Actigraphy | 1 | 2015 | 17 | 0.030 |
Why?
|
| Death | 1 | 2015 | 11 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 701 | 0.030 |
Why?
|
| Food | 1 | 2015 | 31 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2016 | 136 | 0.030 |
Why?
|
| Commerce | 1 | 2015 | 49 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 2014 | 32 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2014 | 17 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 223 | 0.030 |
Why?
|
| Vietnam | 1 | 2014 | 34 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 3 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 3 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 346 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2014 | 15 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 12 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2014 | 30 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 41 | 0.030 |
Why?
|
| Sucrose | 1 | 2013 | 7 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 619 | 0.030 |
Why?
|
| Mice | 1 | 2014 | 68 | 0.030 |
Why?
|
| Analgesics | 1 | 2014 | 28 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2013 | 45 | 0.030 |
Why?
|
| Sleep | 1 | 2014 | 57 | 0.030 |
Why?
|
| Toothpastes | 1 | 2013 | 2 | 0.030 |
Why?
|
| Fluorides, Topical | 1 | 2013 | 5 | 0.030 |
Why?
|
| Tablets | 1 | 2013 | 3 | 0.030 |
Why?
|
| Toothbrushing | 1 | 2013 | 4 | 0.030 |
Why?
|
| Tooth Crown | 1 | 2013 | 7 | 0.030 |
Why?
|
| Registries | 1 | 2015 | 490 | 0.030 |
Why?
|
| Policy Making | 1 | 2013 | 18 | 0.030 |
Why?
|
| Animals | 1 | 2014 | 261 | 0.030 |
Why?
|
| Self Report | 1 | 2015 | 256 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 63 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2013 | 120 | 0.030 |
Why?
|
| Nursing Research | 1 | 2012 | 3 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 524 | 0.030 |
Why?
|
| Femur Neck | 1 | 2012 | 6 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 21 | 0.030 |
Why?
|
| Health Behavior | 1 | 2015 | 374 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 160 | 0.030 |
Why?
|
| Body Composition | 1 | 2012 | 82 | 0.030 |
Why?
|
| Hip Joint | 1 | 2012 | 4 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2012 | 69 | 0.030 |
Why?
|
| Social Support | 1 | 2014 | 214 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 65 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2012 | 253 | 0.030 |
Why?
|
| Educational Status | 1 | 2012 | 205 | 0.030 |
Why?
|
| Dental Arch | 1 | 2011 | 1 | 0.030 |
Why?
|
| Dissection | 1 | 2011 | 1 | 0.030 |
Why?
|
| Cadaver | 1 | 2011 | 2 | 0.030 |
Why?
|
| Bicuspid | 1 | 2011 | 3 | 0.030 |
Why?
|
| Molar | 1 | 2011 | 3 | 0.030 |
Why?
|
| Cuspid | 1 | 2011 | 4 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2011 | 47 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 11 | 0.030 |
Why?
|
| Observer Variation | 1 | 2011 | 40 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2011 | 3 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2012 | 244 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 261 | 0.020 |
Why?
|
| Depth Perception | 1 | 2011 | 1 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2011 | 13 | 0.020 |
Why?
|
| Gait | 1 | 2011 | 7 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 22 | 0.020 |
Why?
|
| Dental Plaque Index | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tooth Demineralization | 1 | 2011 | 1 | 0.020 |
Why?
|
| Elastomers | 1 | 2011 | 1 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 2 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 2 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 52 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 6 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 365 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 165 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 847 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 319 | 0.020 |
Why?
|
| Plant Preparations | 1 | 2008 | 6 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1173 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 567 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1314 | 0.020 |
Why?
|
| Internet | 1 | 2007 | 243 | 0.020 |
Why?
|
| Conflict (Psychology) | 1 | 2005 | 8 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 36 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2005 | 18 | 0.020 |
Why?
|
| Sex Factors | 1 | 2004 | 661 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1478 | 0.010 |
Why?
|